| [1] |
CHEN Weixin.
Analysis of the immune characteristics of peripheral blood lymphocyte subsets in patients with early and advanced non-small cell lung cancer
[J]. Basic & Clinical Medicine, 2026, 46(6): 823-829.
|
| [2] |
ZHANG Zhen, YANG Lianren, HU Junkun, ZHANG Wei, LIANG Wei.
Value of serum D-dimer in evaluating chemotherapy effect and prognosis in patients with non-small cell lung cancer
[J]. Basic & Clinical Medicine, 2026, 46(3): 417-420.
|
| [3] |
LYU Juan, JI Shuo, LIU Ya, SUN Wen, PAN Ruili.
Discriminant analysis on influencing factors of hope level in patients with lung cancer based on decision tree and Logistic regression models
[J]. Basic & Clinical Medicine, 2026, 46(3): 402-410.
|
| [4] |
ZHANG Yufeng, ZHANG Xinna, ZHOU Yanjiao.
PHLPP2 variation is associated with prognosis as well as ferroptosis in patients of advanced lung adenocarcinoma harboring EGFR+TP53 co-mutations
[J]. Basic & Clinical Medicine, 2026, 46(1): 103-108.
|
| [5] |
ZENG Cimei, HUANG Denggao, WANG Lei, LIANG Haimei, MA Ximiao.
Silencing LINC00460 inhibits proliferation and migration of human lung adenocarcinoma cell lines via EZH2
[J]. Basic & Clinical Medicine, 2025, 45(10): 1298-1305.
|
| [6] |
CHEN Qingxia, LIANG Yuling, LUO Yalan, NIU Bin.
Inhibition of NRF1/ABCC1 improves chemosensitivity of human lung adenocarcinoma cell lines to cisplatin
[J]. Basic & Clinical Medicine, 2025, 45(1): 51-59.
|
| [7] |
.
Association of seven antibody levels in lung cancer with chemotherapy effect and prognosis in patients with NSCLC
[J]. Basic & Clinical Medicine, 2024, 44(10): 1383-1387.
|
| [8] |
ZHENG Hong, CHEN Xiaoxia, HAN Lizhou, CHEN Miao, HUANGFU Juan.
Decrease of lncRNA-RMRP expression inhibits proliferation and invasion of human lung cancer cell line A549
[J]. Basic & Clinical Medicine, 2024, 44(7): 974-978.
|
| [9] |
CAO Chenxin, TANG Hui, GENG Ruixuan, GUO Fuping, BAI Chunmei, WANG Yingyi, LI Taisheng.
Correlation between circulating CD4+CD45RA+CD62L+ T cells and prognosis of metastatic non-small cell lung cancer treated with EGFR-TKI
[J]. Basic & Clinical Medicine, 2024, 44(5): 658-664.
|
| [10] |
LIANG Xiangcun, WEI Xiaoyu, LIANG Jian, WANG Qing, GENG Guang.
Anlotinib inhibits proliferation and promotes apoptosis of human non-small cell lung cancer cell lines through miR-16-5p/PD-1 axis
[J]. Basic & Clinical Medicine, 2024, 44(4): 503-512.
|
| [11] |
ZHANG Jing, YANG Zigeng, CAI Wenqin, CAO Weiwei, WEI Hongmei, XUE Xixi, WU Bin.
Inhibition of prohibitin 2 enhances the sensitivity of non-small cell lung cancer cell line A549 to erlotinib
[J]. Basic & Clinical Medicine, 2024, 44(3): 325-332.
|
| [12] |
ZHANG Zhenzhen, LI Yang, GAO Shengbao, XIA Dexin, YAN Yulan.
Recombinant Newcastle virus rL-RVG inhibits proliferation of human lung adenocarcinoma cell lines
[J]. Basic & Clinical Medicine, 2023, 43(10): 1549-1556.
|
| [13] |
ZHANG Jing, YANG Zigeng, WEI Hongmei, NING Haihong, XUE Xixi, JIN Ling, WU Bin.
Knockdown of prohibitin 2 promotes apoptosis in non-small cell lung cancer cell line A549
[J]. Basic & Clinical Medicine, 2023, 43(10): 1522-1529.
|
| [14] |
PAN Shan, LIN Kengqiang, CHEN Shuxing.
Pemetrexed inhibits the proliferation of lung adenocarcinoma cell line A549
[J]. Basic & Clinical Medicine, 2023, 43(9): 1359-1363.
|
| [15] |
YAN Chenhong, JIN Er.
Progress of exosomal PD-L1 in diagnosis and treatment of non-small cell lung cancer
[J]. Basic & Clinical Medicine, 2023, 43(9): 1457-1461.
|
